speb/financial-data huggingface dataset:
IVG.AX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 5823323.00
IVG.AX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 56814.00
IVG.AX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 473104.00
IVG.AX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
IVG.AX balance_sheet (annual, 2022-12-31) — Working Capital: 5350219.00
IVG.AX income_statement (annual, 2023-12-31) — +Operating Expense: 2325138.00
IVG.AX balance_sheet (annual, 2023-12-31) — Accounts Payable: 152466.00
IVG.AX income_statement (annual, 2023-12-31) — Basic Average Shares: 225326449.00
IVG.AX income_statement (annual, 2023-12-31) — Basic EPS: -0.01
IVG.AX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 3686981.00
IVG.AX balance_sheet (annual, 2023-12-31) — Capital Stock: 88623748.00
IVG.AX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 3128352.00
IVG.AX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 3128352.00
IVG.AX balance_sheet (annual, 2023-12-31) — Cash Equivalents: 22323.00
IVG.AX balance_sheet (annual, 2023-12-31) — Cash Financial: 3106029.00
IVG.AX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -7872.00
IVG.AX cash_flow (annual, 2023-12-31) — Cash Flowsfromusedin Operating Activities Direct: -549618.00
IVG.AX cash_flow (annual, 2023-12-31) — Changes In Cash: -557490.00
IVG.AX cash_flow (annual, 2023-12-31) — Classesof Cash Payments: -608725.00
IVG.AX balance_sheet (annual, 2023-12-31) — Common Stock: 88623748.00
IVG.AX balance_sheet (annual, 2023-12-31) — Common Stock Equity: 3426634.00
IVG.AX balance_sheet (annual, 2023-12-31) — Current Assets: 3165394.00
IVG.AX balance_sheet (annual, 2023-12-31) — Current Liabilities: 191415.00
IVG.AX income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 3835.00
IVG.AX income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 3835.00
IVG.AX income_statement (annual, 2023-12-31) — Depreciation Income Statement: 3835.00
IVG.AX income_statement (annual, 2023-12-31) — Diluted Average Shares: 225326449.00
IVG.AX income_statement (annual, 2023-12-31) — Diluted EPS: -0.01
IVG.AX income_statement (annual, 2023-12-31) — EBIT: -2407733.00
IVG.AX income_statement (annual, 2023-12-31) — EBITDA: -2403898.00
IVG.AX cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -1139.00
IVG.AX cash_flow (annual, 2023-12-31) — End Cash Position: 3128352.00
IVG.AX balance_sheet (annual, 2023-12-31) — Foreign Currency Translation Adjustments: -4722.00
IVG.AX cash_flow (annual, 2023-12-31) — Free Cash Flow: -549618.00
IVG.AX balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 254628.00
IVG.AX income_statement (annual, 2023-12-31) — General And Administrative Expense: 2037976.00
IVG.AX balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 3196.00
IVG.AX income_statement (annual, 2023-12-31) — Interest Expense: 3260.00
IVG.AX income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 3260.00
IVG.AX income_statement (annual, 2023-12-31) — Interest Income: 59107.00
IVG.AX income_statement (annual, 2023-12-31) — Interest Income Non Operating: 59107.00
IVG.AX cash_flow (annual, 2023-12-31) — Interest Received Direct: 59107.00
IVG.AX balance_sheet (annual, 2023-12-31) — Invested Capital: 3426634.00
IVG.AX cash_flow (annual, 2023-12-31) — Investing Cash Flow: -7872.00
IVG.AX balance_sheet (annual, 2023-12-31) — Investments And Advances: 388547.00
IVG.AX income_statement (annual, 2023-12-31) — Net Income: -2410993.00
IVG.AX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -2410993.00
IVG.AX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -2410993.00
IVG.AX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -2410993.00
IVG.AX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -2410993.00
IVG.AX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -2410993.00
IVG.AX income_statement (annual, 2023-12-31) — Net Interest Income: 55847.00
IVG.AX cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -7872.00
IVG.AX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 55847.00
IVG.AX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 3423438.00
IVG.AX income_statement (annual, 2023-12-31) — Normalized EBITDA: -2403898.00
IVG.AX income_statement (annual, 2023-12-31) — Normalized Income: -2410993.00
IVG.AX income_statement (annual, 2023-12-31) — Operating Income: -2325138.00
IVG.AX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 225850957.00
IVG.AX balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 259350.00
IVG.AX income_statement (annual, 2023-12-31) — Other Gand A: 1757306.00
IVG.AX income_statement (annual, 2023-12-31) — Other Income Expense: -145537.00
IVG.AX balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 3196.00
IVG.AX balance_sheet (annual, 2023-12-31) — Other Investments: 388547.00
IVG.AX balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 60912.00
IVG.AX income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -145537.00
IVG.AX income_statement (annual, 2023-12-31) — Other Operating Expenses: 242439.00
IVG.AX balance_sheet (annual, 2023-12-31) — Other Payable: 38949.00
IVG.AX balance_sheet (annual, 2023-12-31) — Other Receivables: 1049.00
IVG.AX balance_sheet (annual, 2023-12-31) — Payables: 191415.00
IVG.AX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 191415.00
IVG.AX cash_flow (annual, 2023-12-31) — Paymentsto Suppliersfor Goodsand Services: -608725.00
IVG.AX balance_sheet (annual, 2023-12-31) — Prepaid Assets: 35993.00
IVG.AX income_statement (annual, 2023-12-31) — Pretax Income: -2410993.00
IVG.AX cash_flow (annual, 2023-12-31) — Purchase Of Investment: -7872.00
IVG.AX balance_sheet (annual, 2023-12-31) — Receivables: 1049.00
IVG.AX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 3835.00
IVG.AX balance_sheet (annual, 2023-12-31) — Retained Earnings: -85451742.00
IVG.AX income_statement (annual, 2023-12-31) — Salaries And Wages: 280670.00
IVG.AX income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 40888.00
IVG.AX income_statement (annual, 2023-12-31) — Selling General And Administration: 2078864.00
IVG.AX balance_sheet (annual, 2023-12-31) — Share Issued: 225850957.00
IVG.AX balance_sheet (annual, 2023-12-31) — Stockholders Equity: 3426634.00
IVG.AX balance_sheet (annual, 2023-12-31) — Tangible Book Value: 3423438.00
IVG.AX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
IVG.AX income_statement (annual, 2023-12-31) — Tax Provision: 0.00
IVG.AX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
IVG.AX balance_sheet (annual, 2023-12-31) — Total Assets: 3618049.00
IVG.AX balance_sheet (annual, 2023-12-31) — Total Capitalization: 3426634.00
IVG.AX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 3426634.00
IVG.AX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 191415.00
IVG.AX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 452655.00
IVG.AX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
IVG.AX balance_sheet (annual, 2023-12-31) — Working Capital: 2973979.00
IVG.AX income_statement (annual, 2024-12-31) — +Operating Expense: 695391.00
IVG.AX balance_sheet (annual, 2024-12-31) — Accounts Payable: 184248.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 184248.00
IVG.AX income_statement (annual, 2024-12-31) — Amortization: 3196.00
IVG.AX income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 3196.00
IVG.AX income_statement (annual, 2024-12-31) — Basic Average Shares: 225850957.00
IVG.AX income_statement (annual, 2024-12-31) — Basic EPS: -0.01
IVG.AX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 3128352.00
IVG.AX balance_sheet (annual, 2024-12-31) — Capital Stock: 88623748.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Capital Stock: 88623748.00
IVG.AX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 2039504.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 2039504.00
IVG.AX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 2039504.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 2039504.00
IVG.AX balance_sheet (annual, 2024-12-31) — Cash Equivalents: 22771.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Cash Equivalents: 22771.00
IVG.AX balance_sheet (annual, 2024-12-31) — Cash Financial: 2016733.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Cash Financial: 2016733.00
IVG.AX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 0.00
IVG.AX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 0.00
IVG.AX cash_flow (annual, 2024-12-31) — Cash Flowsfromusedin Operating Activities Direct: -1088848.00
IVG.AX cash_flow (annual, 2024-12-31) — Changes In Cash: -1088848.00
IVG.AX cash_flow (annual, 2024-12-31) — Classesof Cash Payments: -1132551.00
IVG.AX balance_sheet (annual, 2024-12-31) — Common Stock: 88623748.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Common Stock: 88623748.00
IVG.AX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 2198040.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 2198040.00
IVG.AX balance_sheet (annual, 2024-12-31) — Current Assets: 2090941.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Current Assets: 2090941.00
IVG.AX balance_sheet (annual, 2024-12-31) — Current Liabilities: 325748.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 325748.00
IVG.AX income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 3196.00
IVG.AX income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 3196.00
IVG.AX income_statement (annual, 2024-12-31) — Diluted Average Shares: 225850957.00
IVG.AX income_statement (annual, 2024-12-31) — Diluted EPS: -0.01
IVG.AX income_statement (annual, 2024-12-31) — EBIT: -1225431.00
IVG.AX income_statement (annual, 2024-12-31) — EBITDA: -1222235.00
IVG.AX cash_flow (annual, 2024-12-31) — End Cash Position: 2039504.00
IVG.AX cash_flow (annual, 2024-12-31) — Financing Cash Flow: 0.00
IVG.AX balance_sheet (annual, 2024-12-31) — Foreign Currency Translation Adjustments: -4649.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Foreign Currency Translation Adjustments: -4649.00
IVG.AX cash_flow (annual, 2024-12-31) — Free Cash Flow: -1088848.00
IVG.AX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 254701.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 254701.00
IVG.AX income_statement (annual, 2024-12-31) — General And Administrative Expense: 409496.00
IVG.AX income_statement (annual, 2024-12-31) — Interest Expense: 3236.00
IVG.AX income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 3236.00
IVG.AX income_statement (annual, 2024-12-31) — Interest Income: 43703.00
IVG.AX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 43703.00
IVG.AX cash_flow (annual, 2024-12-31) — Interest Received Direct: 43703.00
IVG.AX balance_sheet (annual, 2024-12-31) — Invested Capital: 2198040.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Invested Capital: 2198040.00
IVG.AX cash_flow (annual, 2024-12-31) — Investing Cash Flow: 0.00
IVG.AX balance_sheet (annual, 2024-12-31) — Investments And Advances: 388547.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 388547.00
IVG.AX income_statement (annual, 2024-12-31) — Net Income: -1228667.00
IVG.AX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -1228667.00
IVG.AX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -1228667.00
IVG.AX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -1228667.00
IVG.AX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -1228667.00
IVG.AX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -1228667.00
IVG.AX income_statement (annual, 2024-12-31) — Net Interest Income: 40467.00
IVG.AX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 40467.00
IVG.AX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 2198040.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 2198040.00
IVG.AX income_statement (annual, 2024-12-31) — Normalized EBITDA: -1222235.00
IVG.AX income_statement (annual, 2024-12-31) — Normalized Income: -1228667.00
IVG.AX income_statement (annual, 2024-12-31) — Operating Income: -695391.00
IVG.AX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 225850957.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 225850957.00
IVG.AX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 259350.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 259350.00
IVG.AX income_statement (annual, 2024-12-31) — Other Gand A: 131633.00
IVG.AX income_statement (annual, 2024-12-31) — Other Income Expense: -576939.00
IVG.AX balance_sheet (annual, 2024-12-31) — Other Investments: 388547.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Other Investments: 388547.00
IVG.AX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 44300.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 44300.00
IVG.AX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -576939.00
IVG.AX income_statement (annual, 2024-12-31) — Other Operating Expenses: 282699.00
IVG.AX balance_sheet (annual, 2024-12-31) — Other Payable: 141500.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Other Payable: 141500.00
IVG.AX balance_sheet (annual, 2024-12-31) — Other Receivables: 15988.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Other Receivables: 15988.00
IVG.AX balance_sheet (annual, 2024-12-31) — Payables: 325748.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Payables: 325748.00
IVG.AX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 325748.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 325748.00
IVG.AX cash_flow (annual, 2024-12-31) — Paymentsto Suppliersfor Goodsand Services: -1132551.00
IVG.AX balance_sheet (annual, 2024-12-31) — Prepaid Assets: 35449.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 35449.00
IVG.AX income_statement (annual, 2024-12-31) — Pretax Income: -1228667.00
IVG.AX balance_sheet (annual, 2024-12-31) — Receivables: 15988.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Receivables: 15988.00
IVG.AX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 3196.00
IVG.AX balance_sheet (annual, 2024-12-31) — Retained Earnings: -86680409.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -86680409.00
IVG.AX income_statement (annual, 2024-12-31) — Salaries And Wages: 277863.00
IVG.AX income_statement (annual, 2024-12-31) — Selling General And Administration: 409496.00
IVG.AX balance_sheet (annual, 2024-12-31) — Share Issued: 225850957.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Share Issued: 225850957.00
IVG.AX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 2198040.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 2198040.00
IVG.AX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 2198040.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 2198040.00
IVG.AX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
IVG.AX income_statement (annual, 2024-12-31) — Tax Provision: 0.00
IVG.AX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
IVG.AX balance_sheet (annual, 2024-12-31) — Total Assets: 2523788.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Total Assets: 2523788.00
IVG.AX balance_sheet (annual, 2024-12-31) — Total Capitalization: 2198040.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 2198040.00
IVG.AX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 2198040.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 2198040.00
IVG.AX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 325748.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 325748.00
IVG.AX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 432847.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 432847.00
IVG.AX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
IVG.AX balance_sheet (annual, 2024-12-31) — Working Capital: 1765193.00
IVG.AX balance_sheet (quarterly, 2024-12-31) — Working Capital: 1765193.00
IVG.AX income_statement (annual, 2025-12-31) — +Operating Expense: 1630281.00
IVG.AX balance_sheet (annual, 2025-12-31) — Accounts Payable: 18559.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 18559.00
IVG.AX income_statement (annual, 2025-12-31) — Amortization: 3138.00
IVG.AX income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 3138.00
IVG.AX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 2039504.00
IVG.AX cash_flow (annual, 2025-12-31) — Capital Expenditure: -1063308.00
IVG.AX cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -1050309.00
IVG.AX balance_sheet (annual, 2025-12-31) — Capital Stock: 93971981.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 93971981.00
IVG.AX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 2477267.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 2477267.00
IVG.AX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2477267.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2477267.00
IVG.AX balance_sheet (annual, 2025-12-31) — Cash Financial: 2477267.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Cash Financial: 2477267.00
IVG.AX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 3072840.00
IVG.AX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1063308.00
IVG.AX cash_flow (annual, 2025-12-31) — Cash Flowsfromusedin Operating Activities Direct: -1572206.00
IVG.AX cash_flow (annual, 2025-12-31) — Changes In Cash: 437326.00
IVG.AX cash_flow (annual, 2025-12-31) — Classesof Cash Payments: -1601778.00
IVG.AX balance_sheet (annual, 2025-12-31) — Common Stock: 93971981.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Common Stock: 93971981.00
IVG.AX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 5796110.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 5796110.00
IVG.AX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 3500000.00
IVG.AX cash_flow (annual, 2025-12-31) — Common Stock Payments: -345555.00
IVG.AX balance_sheet (annual, 2025-12-31) — Current Assets: 2526757.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Current Assets: 2526757.00
IVG.AX balance_sheet (annual, 2025-12-31) — Current Liabilities: 246324.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 246324.00
IVG.AX income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 3138.00
IVG.AX income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 3138.00
IVG.AX income_statement (annual, 2025-12-31) — EBIT: -1584492.00
IVG.AX income_statement (annual, 2025-12-31) — EBITDA: -1581354.00
IVG.AX cash_flow (annual, 2025-12-31) — End Cash Position: 2477267.00
IVG.AX cash_flow (annual, 2025-12-31) — Financing Cash Flow: 3072840.00
IVG.AX balance_sheet (annual, 2025-12-31) — Fixed Assets Revaluation Reserve: -388547.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Fixed Assets Revaluation Reserve: -388547.00
IVG.AX balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: -49045.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: -49045.00
IVG.AX cash_flow (annual, 2025-12-31) — Free Cash Flow: -2635514.00
IVG.AX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 90763.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 90763.00
IVG.AX income_statement (annual, 2025-12-31) — General And Administrative Expense: 1293518.00
IVG.AX balance_sheet (annual, 2025-12-31) — Gross PPE: 3487989.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 3487989.00
IVG.AX income_statement (annual, 2025-12-31) — Interest Expense: 1733.00
IVG.AX income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 1733.00
IVG.AX income_statement (annual, 2025-12-31) — Interest Income: 29572.00
IVG.AX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 29572.00
IVG.AX cash_flow (annual, 2025-12-31) — Interest Received Direct: 29572.00
IVG.AX balance_sheet (annual, 2025-12-31) — Invested Capital: 5796110.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 5796110.00
IVG.AX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1063308.00
IVG.AX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 3500000.00
IVG.AX cash_flow (annual, 2025-12-31) — Issuance Of Debt: -81605.00
IVG.AX cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: -81605.00
IVG.AX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 14268.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 14268.00
IVG.AX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 3154445.00
IVG.AX income_statement (annual, 2025-12-31) — Net Income: -1586225.00
IVG.AX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -1586225.00
IVG.AX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -1586225.00
IVG.AX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1586225.00
IVG.AX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1586225.00
IVG.AX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -1586225.00
IVG.AX income_statement (annual, 2025-12-31) — Net Interest Income: 27839.00
IVG.AX cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -81605.00
IVG.AX cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -81605.00
IVG.AX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 27839.00
IVG.AX balance_sheet (annual, 2025-12-31) — Net PPE: 3487989.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Net PPE: 3487989.00
IVG.AX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -12999.00
IVG.AX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 5796110.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 5796110.00
IVG.AX income_statement (annual, 2025-12-31) — Normalized EBITDA: -1581354.00
IVG.AX income_statement (annual, 2025-12-31) — Normalized Income: -1586225.00
IVG.AX income_statement (annual, 2025-12-31) — Operating Income: -1630281.00
IVG.AX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 419275200.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 419275200.00
IVG.AX cash_flow (annual, 2025-12-31) — Other Cash Adjustment Outside Changein Cash: 437.00
IVG.AX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 528355.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 528355.00
IVG.AX income_statement (annual, 2025-12-31) — Other Gand A: 464138.00
IVG.AX income_statement (annual, 2025-12-31) — Other Income Expense: 13079.00
IVG.AX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 27688.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 27688.00
IVG.AX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 13079.00
IVG.AX income_statement (annual, 2025-12-31) — Other Operating Expenses: 333625.00
IVG.AX balance_sheet (annual, 2025-12-31) — Other Payable: 227765.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Other Payable: 227765.00
IVG.AX balance_sheet (annual, 2025-12-31) — Other Properties: 3473721.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Other Properties: 3473721.00
IVG.AX balance_sheet (annual, 2025-12-31) — Other Receivables: 5036.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Other Receivables: 5036.00
IVG.AX balance_sheet (annual, 2025-12-31) — Payables: 246324.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Payables: 246324.00
IVG.AX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 246324.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 246324.00
IVG.AX cash_flow (annual, 2025-12-31) — Paymentsto Suppliersfor Goodsand Services: -1601778.00
IVG.AX balance_sheet (annual, 2025-12-31) — Prepaid Assets: 44454.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 44454.00
IVG.AX income_statement (annual, 2025-12-31) — Pretax Income: -1586225.00
IVG.AX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -12999.00
IVG.AX balance_sheet (annual, 2025-12-31) — Receivables: 5036.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Receivables: 5036.00
IVG.AX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 3138.00
IVG.AX cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -345555.00
IVG.AX balance_sheet (annual, 2025-12-31) — Retained Earnings: -88266634.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -88266634.00
IVG.AX income_statement (annual, 2025-12-31) — Salaries And Wages: 829380.00
IVG.AX income_statement (annual, 2025-12-31) — Selling General And Administration: 1293518.00
IVG.AX balance_sheet (annual, 2025-12-31) — Share Issued: 419275200.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Share Issued: 419275200.00
IVG.AX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 5796110.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 5796110.00
IVG.AX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 5796110.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 5796110.00
IVG.AX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IVG.AX income_statement (annual, 2025-12-31) — Tax Provision: 0.00
IVG.AX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
IVG.AX balance_sheet (annual, 2025-12-31) — Total Assets: 6042434.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Total Assets: 6042434.00
IVG.AX balance_sheet (annual, 2025-12-31) — Total Capitalization: 5796110.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 5796110.00
IVG.AX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 5796110.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 5796110.00
IVG.AX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 246324.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 246324.00
IVG.AX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 3515677.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 3515677.00
IVG.AX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
IVG.AX balance_sheet (annual, 2025-12-31) — Working Capital: 2280433.00
IVG.AX balance_sheet (quarterly, 2025-12-31) — Working Capital: 2280433.00
IVN.TO balance_sheet (annual, 2021-12-31) — Accounts Receivable: 1379000.00
IVN.TO cash_flow (annual, 2021-12-31) — Change In Inventory: 22000.00
IVN.TO cash_flow (annual, 2021-12-31) — Change In Other Working Capital: 1974000.00
IVN.TO cash_flow (annual, 2021-12-31) — Change In Payable: 4122000.00
IVN.TO cash_flow (annual, 2021-12-31) — Change In Payables And Accrued Expense: 4122000.00
IVN.TO cash_flow (annual, 2021-12-31) — Change In Prepaid Assets: -1044000.00
IVN.TO cash_flow (annual, 2021-12-31) — Change In Receivables: -4263000.00
IVN.TO cash_flow (annual, 2021-12-31) — Deferred Income Tax: 3000.00
IVN.TO cash_flow (annual, 2021-12-31) — Deferred Tax: 3000.00
IVN.TO balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 244200000.00
IVN.TO balance_sheet (annual, 2021-12-31) — Duefrom Related Parties Current: 5998000.00
IVN.TO balance_sheet (annual, 2021-12-31) — Employee Benefits: 8292000.00
IVN.TO cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 454000.00
IVN.TO cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: -557000.00
IVN.TO balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Liabilities: 0.00
IVN.TO balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 3925000.00
IVN.TO balance_sheet (annual, 2021-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1395000.00
IVN.TO cash_flow (annual, 2021-12-31) — Provisionand Write Offof Assets: 0.00
IVN.TO cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: -557000.00
IVN.TO balance_sheet (annual, 2021-12-31) — Receivables Adjustments Allowances: -1000.00
IVN.TO income_statement (annual, 2021-12-31) — Special Income Charges: 0.00
IVN.TO balance_sheet (annual, 2021-12-31) — Tradeand Other Payables Non Current: 2908000.00
IVN.TO income_statement (annual, 2021-12-31) — Write Off: 0.00
IVN.TO income_statement (annual, 2022-12-31) — +Operating Expense: 95361000.00
IVN.TO income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
IVN.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 61637000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -51155000.00
IVN.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 1212387222.00
IVN.TO income_statement (annual, 2022-12-31) — Basic EPS: 0.34
IVN.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 608176000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 16304000.00
IVN.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -158655000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 11307000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 2347105000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 597451000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 597451000.00
IVN.TO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: 0.00
IVN.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -9572000.00
IVN.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -173634000.00
IVN.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 176971000.00
IVN.TO cash_flow (annual, 2022-12-31) — Change In Inventory: -16000.00
IVN.TO cash_flow (annual, 2022-12-31) — Change In Payable: 34838000.00
IVN.TO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 34838000.00
IVN.TO cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -23518000.00
IVN.TO cash_flow (annual, 2022-12-31) — Change In Receivables: -5047000.00
IVN.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: 6257000.00
IVN.TO cash_flow (annual, 2022-12-31) — Changes In Cash: -6235000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Common Stock: 2347105000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 2934617000.00
IVN.TO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
IVN.TO balance_sheet (annual, 2022-12-31) — Construction In Progress: 450412000.00
IVN.TO income_statement (annual, 2022-12-31) — Cost Of Revenue: 33912000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Current Assets: 662663000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 546000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Current Debt: 686623000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 687169000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 0.00
IVN.TO balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 0.00
IVN.TO balance_sheet (annual, 2022-12-31) — Current Liabilities: 750831000.00
IVN.TO cash_flow (annual, 2022-12-31) — Deferred Income Tax: -3000.00
IVN.TO cash_flow (annual, 2022-12-31) — Deferred Tax: -3000.00
IVN.TO cash_flow (annual, 2022-12-31) — Depreciation: 5870000.00
IVN.TO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 5870000.00
IVN.TO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 5870000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 221300000.00
IVN.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 1228089887.00
IVN.TO income_statement (annual, 2022-12-31) — Diluted EPS: 0.33
IVN.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 410864000.00
IVN.TO income_statement (annual, 2022-12-31) — EBIT: 338043000.00
IVN.TO income_statement (annual, 2022-12-31) — EBITDA: 343913000.00
IVN.TO income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 254180000.00
IVN.TO cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: -254180000.00
IVN.TO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -4490000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Employee Benefits: 9023000.00
IVN.TO cash_flow (annual, 2022-12-31) — End Cash Position: 597451000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 9652000.00
IVN.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -9572000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Foreign Currency Translation Adjustments: -63830000.00
IVN.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: 18316000.00
IVN.TO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -22900000.00
IVN.TO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 26000.00
IVN.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: -26000.00
IVN.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 17242000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -63830000.00
IVN.TO income_statement (annual, 2022-12-31) — General And Administrative Expense: 44895000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 902830000.00
IVN.TO income_statement (annual, 2022-12-31) — Gross Profit: -33912000.00
IVN.TO income_statement (annual, 2022-12-31) — Interest Expense: 17306000.00
IVN.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 17306000.00
IVN.TO income_statement (annual, 2022-12-31) — Interest Income: 175273000.00
IVN.TO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 175273000.00
IVN.TO cash_flow (annual, 2022-12-31) — Interest Paid Cff: -14375000.00
IVN.TO cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -141000.00
IVN.TO cash_flow (annual, 2022-12-31) — Interest Received Cfo: 14590000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Inventory: 1011000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 3665186000.00
IVN.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -173634000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 9652000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Investments And Advances: 2056692000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Investmentsin Joint Venturesat Cost: 2047040000.00
IVN.TO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
IVN.TO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
IVN.TO balance_sheet (annual, 2022-12-31) — Land And Improvements: 1685000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Loans Receivable: 19629000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 10761000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Long Term Debt: 43946000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 54707000.00
IVN.TO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
IVN.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -714000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 2047040000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Long Term Provisions: 1093000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 71267000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Minority Interest: -93486000.00
IVN.TO income_statement (annual, 2022-12-31) — Minority Interests: -23242000.00
IVN.TO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -39000.00
IVN.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
IVN.TO balance_sheet (annual, 2022-12-31) — Net Debt: 133118000.00
IVN.TO cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 2328000.00
IVN.TO income_statement (annual, 2022-12-31) — Net Income: 410864000.00
IVN.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 410864000.00
IVN.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 434106000.00
IVN.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 410864000.00
IVN.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 410864000.00
IVN.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 320737000.00
IVN.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 434106000.00
IVN.TO cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: 0.00
IVN.TO income_statement (annual, 2022-12-31) — Net Interest Income: 137214000.00
IVN.TO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -13329000.00
IVN.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -714000.00
IVN.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -714000.00
IVN.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 137214000.00
IVN.TO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -118000.00
IVN.TO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -1728000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Net PPE: 902830000.00
IVN.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -158538000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 2934617000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Non Current Accounts Receivable: 15141000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 208356000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 312500000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 310725000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 208356000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 1775000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Non Current Note Receivables: 119231000.00
IVN.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: 322142000.00
IVN.TO income_statement (annual, 2022-12-31) — Normalized Income: 394799179.10
IVN.TO balance_sheet (annual, 2022-12-31) — Notes Receivable: 0.00
IVN.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 176971000.00
IVN.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: -274726000.00
IVN.TO income_statement (annual, 2022-12-31) — Operating Income: -95361000.00
IVN.TO income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
IVN.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 1216754579.00
IVN.TO balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 686623000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 2025000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Other Equity Interest: 141541000.00
IVN.TO income_statement (annual, 2022-12-31) — Other Gand A: 4028000.00
IVN.TO income_statement (annual, 2022-12-31) — Other Income Expense: 278884000.00
IVN.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 72537000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 4372000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 9023000.00
IVN.TO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 2933000.00
IVN.TO income_statement (annual, 2022-12-31) — Other Operating Expenses: 50466000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Other Payable: 3751000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Other Properties: 637835000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Other Receivables: 15742000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Payables: 61637000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 61637000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2025000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 28466000.00
IVN.TO income_statement (annual, 2022-12-31) — Pretax Income: 320737000.00
IVN.TO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 5517000.00
IVN.TO cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 1017000.00
IVN.TO cash_flow (annual, 2022-12-31) — Purchase Of Business: -39000.00
IVN.TO cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: 0.00
IVN.TO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -13329000.00
IVN.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -158655000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Raw Materials: 1011000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Receivables: 35735000.00
IVN.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 33912000.00
IVN.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 5870000.00
IVN.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -714000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Restricted Cash: 13600000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: 509801000.00
IVN.TO income_statement (annual, 2022-12-31) — Salaries And Wages: 40867000.00
IVN.TO cash_flow (annual, 2022-12-31) — Sale Of PPE: 117000.00
IVN.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 44895000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Share Issued: 1216754579.00
IVN.TO income_statement (annual, 2022-12-31) — Special Income Charges: 4529000.00
IVN.TO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 27216000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 2934617000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 2934617000.00
IVN.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 5706179.10
IVN.TO income_statement (annual, 2022-12-31) — Tax Provision: -113369000.00
IVN.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
IVN.TO balance_sheet (annual, 2022-12-31) — Taxes Receivable: 364000.00
IVN.TO cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -13000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Total Assets: 3969285000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 2978563000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Total Debt: 741876000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 2841131000.00
IVN.TO income_statement (annual, 2022-12-31) — Total Expenses: 95361000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 1128154000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 3306622000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 377323000.00
IVN.TO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 161343000.00
IVN.TO income_statement (annual, 2022-12-31) — Total Other Finance Cost: 20753000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 3653000.00
IVN.TO income_statement (annual, 2022-12-31) — Total Unusual Items: 21771000.00
IVN.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 21771000.00
IVN.TO cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 3627000.00
IVN.TO balance_sheet (annual, 2022-12-31) — Working Capital: -88168000.00
IVN.TO income_statement (annual, 2022-12-31) — Write Off: -4555000.00
IVN.TO income_statement (annual, 2023-12-31) — +Operating Expense: 92731000.00
IVN.TO income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
IVN.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 96936000.00
IVN.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -66074000.00
IVN.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 1220711543.00
IVN.TO income_statement (annual, 2023-12-31) — Basic EPS: 0.26
IVN.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 597451000.00
IVN.TO balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 16687000.00
IVN.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -477899000.00
IVN.TO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 11440000.00
IVN.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 2790137000.00
IVN.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 560271000.00
IVN.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 560271000.00
IVN.TO cash_flow (annual, 2023-12-31) — Cash Dividends Paid: 0.00
IVN.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 500270000.00
IVN.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -476998000.00
IVN.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -31566000.00
IVN.TO cash_flow (annual, 2023-12-31) — Change In Inventory: -510000.00
IVN.TO cash_flow (annual, 2023-12-31) — Change In Payable: 47298000.00
IVN.TO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 47298000.00
IVN.TO cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -21519000.00
IVN.TO cash_flow (annual, 2023-12-31) — Change In Receivables: -16752000.00
IVN.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: 8517000.00
IVN.TO cash_flow (annual, 2023-12-31) — Changes In Cash: -8294000.00
IVN.TO balance_sheet (annual, 2023-12-31) — Common Stock: 2790137000.00
IVN.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 3698478000.00
IVN.TO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 429704000.00
IVN.TO balance_sheet (annual, 2023-12-31) — Construction In Progress: 948876000.00
IVN.TO income_statement (annual, 2023-12-31) — Cost Of Revenue: 0.00
IVN.TO balance_sheet (annual, 2023-12-31) — Current Assets: 648833000.00
IVN.TO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 675000.00
IVN.TO balance_sheet (annual, 2023-12-31) — Current Debt: 886202000.00
IVN.TO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 886877000.00
IVN.TO balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 0.00
IVN.TO balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 0.00
IVN.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 997281000.00
IVN.TO cash_flow (annual, 2023-12-31) — Depreciation: 2295000.00
IVN.TO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 2295000.00
IVN.TO income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 1915000.00
IVN.TO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 2295000.00
IVN.TO income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 1915000.00
IVN.TO income_statement (annual, 2023-12-31) — Depreciation Income Statement: 1915000.00